What Indians Think of the COVID-19 vaccine: A qualitative study comprising focus group discussions and thematic analysis. Issue 3 (May 2021)

• Record Type: Journal Article
• Authors: Kumari, Archana; Ranjan, Piyush; Chopra, Sakshi; Kaur, Divjyot; Kaur, Tanveer; Kalanidhi, Kamal Bandhu; Goel, Aastha; Singh, Amandeep; Baitha, Upendra; Prakash, Bindu; Vikram, Naval K.
• Is Part Of: Diabetes & metabolic syndrome. Volume 15:Issue 3(2021)
• Page Start: 679
• Page End: 682
• Publication Date: 2021-05
• Subjects: COVID-19 vaccine -- Focus group discussion -- Acceptance -- Hesitancy -- India; Diabetes -- Periodicals; Metabolism -- Disorders -- Periodicals; Diabetes Mellitus -- Periodicals; Metabolic Diseases -- Periodicals; Diabète -- Périodiques; Métabolisme, Troubles du -- Périodiques; Endocrinologie -- Périodiques; Diabète -- Physiopathologie -- Périodiques; Diabetes; Metabolism -- Disorders; Electronic journals; Periodicals; 616.462
• DOI: 10.1016/j.dsx.2021.03.021
• Languages: English
• ISSNs: 1871-4021

Abstract

Abstract: Background and aims: The study aims to interpret current knowledge, attitude, perceptions and concerns regarding COVID-19 vaccine in the Indian population. Methods: Eight focus group discussions were conducted. Participants were recruited via purposive sampling. Discussions were recorded and transcribed verbatim. Key themes were extracted using thematic analysis method. Results: There were 19 males and 24 females, with a mean age of 36 ± 11 years. Sub-themes identified were knowledge, attitude, perception and concerns regarding COVID-19 vaccine, leading to the main theme, i.e., views about the COVID-19 vaccine. Conclusion: People have mixed perceptions regarding COVID-19 vaccine. Channelling correct messages may improve people's willingness to get vaccinated. Highlights: COVID-19 vaccine acceptance is determined by people's knowledge, attitude and concerns. Diverse sources of information are providing contradictory details. Crucial to deliver correct information to strengthen positive attitude towards COVID-19 vaccine.